Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-TECHNE Corp Director's Dealing 2013

Aug 5, 2013

30718_dirs_2013-08-05_f3cb3f4b-fa91-4a9e-b790-9b05f58f1aaf.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TECHNE CORP /MN/ (TECH)
CIK: 0000842023
Period of Report: 2013-08-01

Reporting Person: Bazan J. Fernando (Chief Technical Officer)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2013-08-01 Stock Option (Right to Buy) $76.02 A 10000 Acquired 2020-08-01 Common Stock (10000) Direct

Footnotes

F1: Vests 3,333 shares on August 1, 2014 and August 1, 2015; 3,334 shares on August 1, 2016.